semaglutide & tirzepatide weight loss Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Trying to decide between semaglutide

Changing epidemiology, global trends and implications for outcomes of NAFLD

The MHRA is the medicines regulator for the whole of the United Kingdom, including Northern Ireland, following the implementation of the Windsor Framework for medicines (from 1 January 2025)

Women have also complained about lightheadedness and dizziness when using GLP-1 weight loss drugs, but these are likely due to lower blood sugar levels or a lack of proper hydration

GLP-1s for Obstructive Sleep Apnea Obstructive sleep apnea is a disorder in which people briefly stop breathing or breathe very shallowly during sleep, multiple times per hour